A Pennsylvania woman credits her early detection of breast cancer to a combination of ultrasound and mammography testing of her dense breast tissue, according to a report by the Scranton Times-Tribune in Pennsylvania.

Mammography screening for women with a history of breast cancer has declined since the U.S. Preventive Services Task Force (USPSTF) released its 2009 guidelines recommending that mammography examinations be deferred until a woman is at least 50 years old.  

In 2013, the American College of Radiology and Society of Breast Imaging created standardized curricula for U.S. breast imaging fellowships. Structural and organizational guidance for these fellowships, however, need improvement, according to an editorial published Aug. 14 in the Journal of the American College of Radiology.

While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of the American College of Cardiology notes individuals treated with trastuzumab-based chemotherapy have a higher risk for HF—but they are not monitored for it, despite recommendations.

Screening mammography recall rates may be associated with a radiologist's annual reading volume and level of experience, according to research published July 20 in the Journal of the American College of Radiology.

Yehudit Abrams, MD, a former NASA biomedical scientist, is planning to develop a handheld ultrasound device that will allow women to monitor their breasts in their homes, according to a July 15 report by The Times of Israel.

Researchers at the University of California, San Francisco (UCSF) found that follow-up imaging for women with non-metastatic breast cancer strongly varies across the U.S. Differences are thought to be caused by varying common clinical practices implemented by multiple physician groups and hospitals.

Not offering breast cancer screening to low-risk women and implementing risk-stratified breast screening programs may improve the cost-effectiveness of screening programs and reduce overdiagnosis, according to research published July 5 in JAMA Oncology.